These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2564784)

  • 1. Effects of pipecuronium and pancuronium on the isolated rabbit heart.
    Deam RK; Soni N
    Br J Anaesth; 1989 Mar; 62(3):287-9. PubMed ID: 2564784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular and cardiovascular effects of pipecuronium.
    Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL
    Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac effects of non-depolarizing neuromuscular blocking agents pancuronium,vecuronium, and rocuronium in isolated rat atria.
    Melnikov AL; Malakhov KY; Helgesen KG; Lathrop DA
    Gen Pharmacol; 1999 Oct; 33(4):313-7. PubMed ID: 10523069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopharmacology of Arduan].
    Mészáros C
    Acta Pharm Hung; 1992 May; 62(3):133-8. PubMed ID: 1354406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular effects of pipecuronium bromide.
    Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS
    Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the interaction of steroidal neuromuscular blocking drugs with cardiac muscarinic receptors.
    Appadu BL; Lambert DG
    Br J Anaesth; 1994 Jan; 72(1):86-8. PubMed ID: 7906535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative potency of pipecuronium bromide and pancuronium bromide.
    Stanley JC; Mirakhur RK
    Br J Anaesth; 1989 Dec; 63(6):754-5. PubMed ID: 2558699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More information about pipecurium, a new neuromuscular blocking agent.
    Boros M
    Anesthesiology; 1983 Jan; 58(1):108. PubMed ID: 6293346
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
    Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
    Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the haemodynamic effects of pipecuronium and pancuronium during fentanyl anaesthesia.
    Stanley JC; Carson IW; Gibson FM; McMurray TJ; Elliott P; Lyons SM; Mirakhur RK
    Acta Anaesthesiol Scand; 1991 Apr; 35(3):262-6. PubMed ID: 1645492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations on the neuromuscular blocking action of pipecuronium in the dog.
    Jones RS
    Res Vet Sci; 1987 Jul; 43(1):101-3. PubMed ID: 2820005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of non-depolarizing neuromuscular blocking agents on the release of acetylcholine from the right atrium of the guinea pig.
    Manabe N
    Acta Med Okayama; 1997 Feb; 51(1):13-8. PubMed ID: 9057930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Criteria for use of pancuronium bromide, vecuronium bromide, atracurium besylate, tubocurarine chloride, metocurine iodide, pipecuronium bromide, and doxacurium chloride in adults.
    Donnelly AJ; Golembiewski JA; Skupski R; Wojtynek JE
    Clin Pharm; 1992 May; 11(5):435-41. PubMed ID: 1349856
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacology of pipecuronium bromide.
    Larijani GE; Bartkowski RR; Azad SS; Seltzer JL; Weinberger MJ; Beach CA; Goldberg ME
    Anesth Analg; 1989 Jun; 68(6):734-9. PubMed ID: 2544118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative potency of steroidal neuromuscular blocking drugs and isobolographic analysis of the interaction between rocuronium and other aminosteroids.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Jul; 75(1):37-42. PubMed ID: 7669466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cardiovascular effects of pipecuronium versus vecuronium in patients receiving sufentanil anesthesia for myocardial revascularization.
    Starr NJ; Kraenzler EJ; Wong D; Koehler LS; Estafanous FG
    J Cardiothorac Vasc Anesth; 1991 Apr; 5(2):116-9. PubMed ID: 1677820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of histamine N-methyltransferase (HNMT) in vitro by neuromuscular relaxants.
    Futo J; Kupferberg JP; Moss J
    Biochem Pharmacol; 1990 Feb; 39(3):415-20. PubMed ID: 1968337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical, electromyographic and electromechanographic studies of the nondepolarizing muscle relaxant pipecurium bromide (Arduan)].
    Stoianov E; Shtŭrbova M; Marinova M
    Khirurgiia (Sofiia); 1988; 41(5):35-7. PubMed ID: 2851068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.